chr5-80654725-GC-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_002439.5(MSH3):c.-1delC variant causes a start retained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
MSH3
NM_002439.5 start_retained
NM_002439.5 start_retained
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.447
Genes affected
MSH3 (HGNC:7326): (mutS homolog 3) The protein encoded by this gene forms a heterodimer with MSH2 to form MutS beta, part of the post-replicative DNA mismatch repair system. MutS beta initiates mismatch repair by binding to a mismatch and then forming a complex with MutL alpha heterodimer. This gene contains a polymorphic 9 bp tandem repeat sequence in the first exon. The repeat is present 6 times in the reference genome sequence and 3-7 repeats have been reported. Defects in this gene are a cause of susceptibility to endometrial cancer. [provided by RefSeq, Mar 2011]
DHFR (HGNC:2861): (dihydrofolate reductase) Dihydrofolate reductase converts dihydrofolate into tetrahydrofolate, a methyl group shuttle required for the de novo synthesis of purines, thymidylic acid, and certain amino acids. While the functional dihydrofolate reductase gene has been mapped to chromosome 5, multiple intronless processed pseudogenes or dihydrofolate reductase-like genes have been identified on separate chromosomes. Dihydrofolate reductase deficiency has been linked to megaloblastic anemia. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSH3 | NM_002439.5 | c.-1delC | start_retained_variant | 1/24 | ENST00000265081.7 | NP_002430.3 | ||
MSH3 | NM_002439.5 | c.-1delC | 5_prime_UTR_variant | 1/24 | ENST00000265081.7 | NP_002430.3 | ||
DHFR | NM_000791.4 | c.-237delG | 5_prime_UTR_variant | 1/6 | ENST00000439211.7 | NP_000782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH3 | ENST00000265081 | c.-1delC | start_retained_variant | 1/24 | 1 | NM_002439.5 | ENSP00000265081.6 | |||
MSH3 | ENST00000667069 | c.-1delC | start_retained_variant | 1/22 | ENSP00000499502.1 | |||||
MSH3 | ENST00000265081 | c.-1delC | 5_prime_UTR_variant | 1/24 | 1 | NM_002439.5 | ENSP00000265081.6 | |||
DHFR | ENST00000439211.7 | c.-237delG | 5_prime_UTR_variant | 1/6 | 1 | NM_000791.4 | ENSP00000396308.2 | |||
MSH3 | ENST00000667069 | c.-1delC | 5_prime_UTR_variant | 1/22 | ENSP00000499502.1 | |||||
MSH3 | ENST00000670357.1 | n.-1delC | start_retained_variant | 1/25 | ENSP00000499791.1 | |||||
MSH3 | ENST00000670357.1 | n.-1delC | non_coding_transcript_exon_variant | 1/25 | ENSP00000499791.1 | |||||
MSH3 | ENST00000670357.1 | n.-1delC | 5_prime_UTR_variant | 1/25 | ENSP00000499791.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 34
GnomAD4 exome
Cov.:
34
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 02, 2021 | The c.-1delC variant is located in the 5' untranslated region (5’UTR) of the MSH3 gene. This variant results from the deletion of one nucleotide upstream from the first translated codon. Based on nucleotide sequence alignment, this position is poorly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.